Add to ORKG44th Congress of the European-Society-for-Medical-Oncology (ESMO) -- SEP 27-OCT 01, 2019 -- Barcelona, SPAINucuncu, Muhammed zubeyr/0000-0003-4638-1059;WOS: 000491295501072[No abstract available]European Soc Med Oncol, Japanese Soc Med Onco
Ovarian reserve (OR)determines the quantity and quality of follicles present in the ovary. It is ind...
BACKGROUND: Endocrine measures of ovarian reserve before breast cancer treatment may predict postche...
Young women with breast cancer face treatments that impair ovarian function, but it is not known if ...
Female patients undergoing anticancer treatment are at elevated risk of adverse ovarian outcomes inc...
Breast cancer is the most common invasive cancer in women of reproductive age. In young women, chemo...
Breast cancer is the most common invasive cancer in women of reproductive age. In young women, chemo...
International audienceAim: Women of reproductive age with breast cancer generally receive gonadotoxi...
Background: A cohort study was performed to identify ovarian reserve markers (ORM) that predicts ame...
Purpose: To predict embryo/oocyte cryopreservation cycle (ECC) outcomes in breast cancer patients st...
AbstractAimImproving survival for women with early breast cancer (eBC) requires greater attention to...
International audienceBackground: Long-term consequences of cancer treatments in young women, and es...
PurposeAccurate diagnosis and prediction of loss of ovarian function after chemotherapy for premenop...
41st Annual Congress of the European-Society-for-Medical-Oncology (ESMO) -- OCT 07-11, 2016 -- Copen...
Ovarian reserve (OR)determines the quantity and quality of follicles present in the ovary. It is ind...
Background: Worldwide, breast cancer (BC) is the most common malignancy in the female population. In...
Ovarian reserve (OR)determines the quantity and quality of follicles present in the ovary. It is ind...
BACKGROUND: Endocrine measures of ovarian reserve before breast cancer treatment may predict postche...
Young women with breast cancer face treatments that impair ovarian function, but it is not known if ...
Female patients undergoing anticancer treatment are at elevated risk of adverse ovarian outcomes inc...
Breast cancer is the most common invasive cancer in women of reproductive age. In young women, chemo...
Breast cancer is the most common invasive cancer in women of reproductive age. In young women, chemo...
International audienceAim: Women of reproductive age with breast cancer generally receive gonadotoxi...
Background: A cohort study was performed to identify ovarian reserve markers (ORM) that predicts ame...
Purpose: To predict embryo/oocyte cryopreservation cycle (ECC) outcomes in breast cancer patients st...
AbstractAimImproving survival for women with early breast cancer (eBC) requires greater attention to...
International audienceBackground: Long-term consequences of cancer treatments in young women, and es...
PurposeAccurate diagnosis and prediction of loss of ovarian function after chemotherapy for premenop...
41st Annual Congress of the European-Society-for-Medical-Oncology (ESMO) -- OCT 07-11, 2016 -- Copen...
Ovarian reserve (OR)determines the quantity and quality of follicles present in the ovary. It is ind...
Background: Worldwide, breast cancer (BC) is the most common malignancy in the female population. In...
Ovarian reserve (OR)determines the quantity and quality of follicles present in the ovary. It is ind...
BACKGROUND: Endocrine measures of ovarian reserve before breast cancer treatment may predict postche...
Young women with breast cancer face treatments that impair ovarian function, but it is not known if ...